Version 5.4
Bos taurus Protein: PPP2R3A
Summary
InnateDB Protein IDBP-690831.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol PPP2R3A
Protein Name protein phosphatase 2, regulatory subunit B'', alpha
Synonyms PPP2R3A;
Species Bos taurus
Ensembl Protein ENSBTAP00000011215
InnateDB Gene IDBG-638716 (PPP2R3A)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 9 interaction(s) predicted by orthology.
Predicted by orthology
Total 9 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005509 calcium ion binding
GO:0005515 protein binding
Biological Process
GO:0001754 eye photoreceptor cell differentiation
GO:0007525 somatic muscle development
GO:0045732 positive regulation of protein catabolic process
GO:0090090 negative regulation of canonical Wnt signaling pathway
GO:0090249 regulation of cell motility involved in somitogenic axis elongation
GO:0090263 positive regulation of canonical Wnt signaling pathway
Cellular Component
GO:0000159 protein phosphatase type 2A complex
Protein Structure and Domains
PDB ID
InterPro IPR002048 EF-hand domain
PFAM PF00036
PF13202
PF13405
PRINTS
PIRSF
SMART SM00054
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E1BIU6
UniProt Splice Variant
Entrez Gene 787607
UniGene Bt.66280
RefSeq XP_005196043
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02003010 DAAA02003011 DAAA02003012
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca